Social Security Claiming Decision Weighing Full Retirement Age vs Delayed Benefits Trumps 10 Billion IRS Lawsuit Dropped After DOJ Agrees to Create 18 Billion Lawfare Compensation Fund Chip Stock Rally Drives Wall Street Higher Micron Surges 9 on AI Optimism ProfitTaking Strategy CNBC Analyst Trims Position After 80 Rally Since April Global Markets Gain on Hopes of USIran Progress Oil Uncertainty Persists Above 100 AIDriven Drug Discovery May Accelerate Treatments for Brain Conditions ACET Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response OBIO Q1 2026 Earnings Narrowed Loss as EPS Surpasses Estimates Stock Posts Modest Decline EVGO Q1 2026 Earnings Narrower Loss Surpasses Analyst Expectations Amidst Operational Gains LUCY Q1 2026 Earnings EPS Surprises with a 2282 Beat Despite Missing Revenue Details Marine Petroleum Trust MARPS Q4 2025 Earnings Trust Reports EPS of 008 Stock Declines 16 Brilliant Earth Group Inc BRLT Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Operational Progress CMSC Holds Steady Near 2266 CMS Energy Hybrid Notes Attract Income Seekers Amidst Stable Trading GoDaddy Inc GDDY Slips 16 as Broader Market Pressure Weighs on Domain and Hosting Giant Covenant Logistics Holds Steady Near Support Amid Mixed Market Signals Guggenheim Active Allocation Fund GUG Posts Modest Gain Holds Above Key Support Cracker Barrel CBRL Sees Modest Uptick as Shares Test Key Resistance Levels Jazz Pharmaceuticals JAZZ Edges Higher as Stock Consolidates Near Support Levels Haverty Furniture Edges Higher as Stock Holds Near Key Support Levels Camden National Corporation CAC Holds Near Support Amid Modest Decline Pitney Bowes PBI Edges Higher as Stock Holds Key Support Zone Cohen Steers Real Estate Opportunities and Income Fund RLTY Edges Higher Amid Modest Gains Silvercorp Metals SVM Slips 19 as Selling Pressure Tests Key Support Levels Consumer Sentiment Falls to Record Low in May as Rising Gas Prices Amid Iran Conflict Weigh on Outlook FIS Q1 2026 Earnings EPS Surpasses Estimates by 464 as Stock Moves Lower Intellia Therapeutics NTLA Gains 186 as Gene Editing Stocks Find Support